Declared clinical rules

Medical conditions are not ignored.

NUTRIMI separates calculable daily nutrition targets from food-level compatibility warnings. Rules are applied only to nutrients represented in the software data and do not replace diagnosis, prescription or professional review.

BITE checks a nutrition rule before displaying it
Two distinct layersQuantitative diary targets and contextual food warnings.
  • Technical authorDiego Russo
  • Verified2 August 2026
  • PrioritySafety limits take precedence
  • TransparencyPublic sources and limits
Active targets

Which conditions change monitored nutrients.

Hypertension: salt and potassium. Kidney disease: salt, potassium, phosphorus and protein by weight and stage. Dyslipidaemia: saturated fat, fibre and sugars. Diabetes or insulin resistance: sugars and fibre. Fatty liver disease: sugars and saturated fat. Gout: purines and sugars. Phenylketonuria: phenylalanine. Crohn's disease, colitis and diverticulitis: fibre by flare or remission.

Kidney disease

Before dialysis, protein is capped at weight × 0.8 g; during dialysis the goal is weight × 1.2 g. Potassium and phosphorus remain separate limits.

Bowel disease

During a flare, fibre is capped at 12 g; in remission it becomes a minimum goal of 30 g.

Conflicts

A maximum limit overrides a minimum goal. Among limits the lowest wins; among goals the highest wins.

Food-level warnings

Coeliac disease, IBS and reflux are not reduced to a generic progress bar.

For conditions driven mainly by exclusions, individual tolerance or contextual triggers, the software shows warnings on individual foods. This avoids inventing a daily threshold unsupported by the data. Warnings use selected conditions and available composition data, but actual compatibility may depend on diagnosis, phase, quantity, preparation and treatment.

Not an automated clinical decision

NUTRIMI does not diagnose a condition or change treatment. General thresholds need professional personalisation, particularly for kidney function, electrolytes, PKU, active bowel disease and comorbidity.

Professional responsibility